indican has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giebułtowicz, J; Koziorowski, D; Księżarczyk, K; Raćkowska, E; Sankowski, B; Szlufik, S | 1 |
| Barichella, M; Bianchi, F; Bolliri, C; Cancello, R; Cassani, E; Cavanna, F; Cereda, E; Cestaro, B; Iorio, L; Pezzoli, G; Zampella Maria, P | 1 |
2 other study(ies) available for indican and Parkinson Disease
| Article | Year |
|---|---|
Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson's disease.
Topics: Adult; Biomarkers; Cresols; Female; Humans; Indican; Male; Middle Aged; Parkinson Disease; Sulfuric Acid Esters | 2020 |
Increased urinary indoxyl sulfate (indican): new insights into gut dysbiosis in Parkinson's disease.
Topics: Aged; Case-Control Studies; Comorbidity; Constipation; Dysbiosis; Female; Gastrointestinal Microbiome; Humans; Indican; Male; Middle Aged; Parkinson Disease | 2015 |